TY - JOUR
T1 - Vector-borne diseases
AU - More, Simon J.
AU - Bicout, Dominique
AU - Bøtner, Anette
AU - Butterworth, Andrew
AU - Calistri, Paolo
AU - Koeijer, Aline De
AU - Depner, Klaus
AU - Edwards, Sandra
AU - Garin-Bastuji, Bruno
AU - Good, Margaret
AU - Gortazar Schmidt, Christian
AU - Michel, Virginie
AU - Miranda, Miguel Angel
AU - Nielsen, Søren Saxmose
AU - Raj, Mohan
AU - Sihvonen, Liisa
AU - Spoolder, Hans
AU - Thulke, Hans-Hermann
AU - Velarde, Antonio
AU - Willeberg, Preben
AU - Winckler, Christoph
AU - Bau, Andrea
AU - Beltran-Beck, Beatriz
AU - Carnesecchi, Edoardo
AU - Casier, Pascal
AU - Czwienczek, Ewelina
AU - Dhollander, Sofie
AU - Georgiadis, Marios
AU - Gogin, Andrey
AU - Pasinato, Luca
AU - Richardson, Jane
AU - Riolo, Francesca
AU - Rossi, Gianluca
AU - Watts, Matthew
AU - Lima, Eliana
AU - Stegeman, Jan Arend
PY - 2017
Y1 - 2017
N2 - After a request from the Europea n Commission, EFSA’s Panel on Animal Health and Welfaresummarised the main characteristics of 36 vector-borne disease s (VBDs) in 36 web-based storymaps.The risk of introduction in the EU through movement of livestock or pets was assessed for eac h of the36 VBDs individually, using a semiquantitative Metho d to INTegrate all relevant RISK aspects(MINTRI SK model), which was further modified to a European scale into the EFSA-VBD-RISK-m odel .Only eight of the 36 VBD-agents had an overall rate of introduction in the EU (being the combinationof the rate of entry, vector transmission and establishment) which was estimated to be above 0.001introductions per year. These were Crimean-Congo haemorrhagic fever virus, bluetongue virus, WestNile virus, Schmallenberg virus, Hepatozoon canis, Leishmania infantum, Bunyamwera virus andHighlands J. virus. For these eight dise ases, the annual extent of spread was assessed, assuming theimplementation of available, authorised prevention and control measures in the EU. Further, theprobability of overwintering was assessed, as well as the possible impact of the VBDs on public health,animal health and farm production. For the other 28 VBD-agents for which the rate of introduction wasestimated to be very low, no further asse ssments were made. Due to the uncertainty related to someparameters used for the risk assessment or the instable or unpredictability disease situation in some ofthe source regions, it is recommended to update the assessment when new information becomesavailable. Since this risk assessment was carried out for large regions in the EU for many VBD-agents,it should be considered as a first screening. If a more detailed risk assessment for a specificVBDiswished for on a national or subnational level, the EFSA-VBD-RISK-model is freely available for thispurpose.
AB - After a request from the Europea n Commission, EFSA’s Panel on Animal Health and Welfaresummarised the main characteristics of 36 vector-borne disease s (VBDs) in 36 web-based storymaps.The risk of introduction in the EU through movement of livestock or pets was assessed for eac h of the36 VBDs individually, using a semiquantitative Metho d to INTegrate all relevant RISK aspects(MINTRI SK model), which was further modified to a European scale into the EFSA-VBD-RISK-m odel .Only eight of the 36 VBD-agents had an overall rate of introduction in the EU (being the combinationof the rate of entry, vector transmission and establishment) which was estimated to be above 0.001introductions per year. These were Crimean-Congo haemorrhagic fever virus, bluetongue virus, WestNile virus, Schmallenberg virus, Hepatozoon canis, Leishmania infantum, Bunyamwera virus andHighlands J. virus. For these eight dise ases, the annual extent of spread was assessed, assuming theimplementation of available, authorised prevention and control measures in the EU. Further, theprobability of overwintering was assessed, as well as the possible impact of the VBDs on public health,animal health and farm production. For the other 28 VBD-agents for which the rate of introduction wasestimated to be very low, no further asse ssments were made. Due to the uncertainty related to someparameters used for the risk assessment or the instable or unpredictability disease situation in some ofthe source regions, it is recommended to update the assessment when new information becomesavailable. Since this risk assessment was carried out for large regions in the EU for many VBD-agents,it should be considered as a first screening. If a more detailed risk assessment for a specificVBDiswished for on a national or subnational level, the EFSA-VBD-RISK-model is freely available for thispurpose.
U2 - 10.2903/j.efsa.2017.4793
DO - 10.2903/j.efsa.2017.4793
M3 - Journal article
SN - 1831-4732
VL - 15
JO - E F S A Journal
JF - E F S A Journal
IS - 5
M1 - 4793
ER -